Sponsor pipeline

Boehringer Ingelheim clinical trial pipeline

Get alerts when Boehringer Ingelheim's trials change

95 active trials 48 recruiting 24 Phase 3 27 disease areas 66 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-02

What changed in the last 30 days showing 31 of 66 changes on 18 trials

2026-09-25
Trial terminated
Trial terminated: Sponsor decision
Final enrollment: 14 participants (planned 135)
NCT06882746 A Study to Test Different Doses of BI 765049 in People With Advanced Cancer of the Colon… · Phase 1
2026-09-23
Primary completion pushed: 2026-09-02 → 2026-12-10
NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With… · Phase 3
2026-09-17
Primary completion pushed: 2026-09-01 → 2027-03-31
NCT06077500 DAREONᵀᴹ-8: A Study to Test How Well Different Doses of BI 764532 in Addition to Standard… · Phase 1
2026-09-04
Primary completion pushed: 2027-01-17 → 2027-06-21
Enrollment increased: 35 → 70 participants
Completion pushed: 2027-01-17 → 2027-06-21
NCT07754474 A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in… · Phase 1
2026-09-17
Primary endpoint(s) modified
NCT07063316 SGLT2 Inhibitors and Renal Anemia in Japan: RWD
2026-10-01
Enrollment closed, study ongoing
NCT07708493 A Study to Test How BI 3034701 is Taken up and Processed by the Body in Healthy Men With… · Phase 1
2026-09-30
Trial completed
NCT07727785 A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole · Phase 1
2026-09-26
Enrollment closed, study ongoing
Final enrollment: 81 participants (planned 71)
NCT07036523 A Study to Find Out Whether BI 765423 Has an Effect on Lung Function in People With… · Phase 2
2026-09-23
Recruitment opened
Trial sites expanded: 163 → 166 locations
NCT07540988 FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… · Phase 3
2026-09-23
Enrollment closed, study ongoing
Primary completion moved earlier: 2028-08-30 → 2026-12-31
Completion moved earlier: 2028-08-30 → 2026-12-31
NCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… · Phase 3
2026-09-23
Enrollment closed, study ongoing
NCT06238622 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary… · Phase 3
2026-09-24
Recruitment opened
NCT07781631 A Study in Healthy Men to Test Whether Carbamazepine Influences the Amount of Verducatib… · Phase 1
2026-09-24
Enrollment closed, study ongoing
NCT07693231 A Study to Test How Well Different Doses of BI 3034701 Are Tolerated by Japanese Healthy… · Phase 1
2026-09-24
Recruitment opened
NCT07754474 A Study to Test How Well Different and Multiple Doses of BI 3034701 Are Tolerated in… · Phase 1
2026-09-22
Recruitment opened
Start date pushed: 2026-09-07 → 2026-09-21
NCT07744152 A Study to Test How Well Different Doses of BI 3822971 Are Tolerated by People With… · Phase 1
2026-09-11
Enrollment closed, study ongoing
Final enrollment: 342 participants (planned 300)
NCT07662122 A Study to Test Whether BI 3034701 Helps People to Lose Weight Who Live With Obesity or… · Phase 2
2026-09-16
Trial completed
Enrollment increased: 4 → 8 participants
NCT07693218 A Study in Healthy Men to Test How BI 1815368 is Processed in the Body · Phase 1
2026-09-16
Recruitment opened
NCT07789028 A Study in Healthy People to Test How Zongertinib is Taken up in the Body When Given as… · Phase 1
2026-09-16
Enrollment closed, study ongoing
NCT07727785 A Study in Healthy People to Compare Two Tablet Formulations of Pramipexole · Phase 1
2026-09-10
Recruitment opened
NCT07774325 A Study in Healthy Men to Find Out How Blocking Certain Transport Proteins Affects the… · Phase 1

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-01 NCT07851103 A Study to Test Different Doses of BI 3968621 When Given Alone or With Ezabenlimab in… Phase 1 Not Yet Recruiting
2026-09-30 NCT07850050 SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With… Phase 3 Not Yet Recruiting
2026-09-30 NCT07850063 ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and… Phase 3 Not Yet Recruiting
2026-09-29 NCT07845630 A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat /… Phase 1 Not Yet Recruiting
2026-09-28 NCT07843940 A Study to Test Obrixtamig in Combination With Pumitamig in People With Advanced Small… Phase 1/2 Not Yet Recruiting
2026-09-23 NCT07837648 A Study to Test How Much BI 3034701 Gets Into the Blood in Healthy People When Given in… Phase 1 Not Yet Recruiting

Active trials by phase

Phase 1
41
Phase 1/2
5
Phase 2
15
Phase 3
24
Not charted: 10 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Active trials top 25 of 95

NCT IDTitleConditionStatusUpdated
Phase 3
NCT06424288 A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With… Heart Failure Recruiting 2026-10-01
NCT06632444 LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called… Metabolic Dysfunction Associated Steatohepatitis (MASH) Recruiting 2026-10-01
NCT06632457 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver… Metabolic Dysfunction Associated Steatohepatitis Recruiting 2026-10-01
NCT06872892 The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… Bronchiectasis Recruiting 2026-10-01
NCT06935370 A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps… Heart Failure Recruiting 2026-10-01
NCT07540988 FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing… Interstitial Lung Diseases Recruiting 2026-10-01
NCT07064473 EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin… Diabetes Mellitus, Type 2 Recruiting 2026-09-30
NCT07201922 A Study to Test Whether Nerandomilast Can Help Slow Down Changes in the Lung in People… Familial Pulmonary Fibrosis Recruiting 2026-09-30
NCT07220083 A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition… Focal Segmental Glomerulosclerosis Recruiting 2026-09-30
NCT07497087 A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis Systemic Sclerosis Recruiting 2026-09-30
NCT07754461 A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood… Type 2 Diabetes Recruiting 2026-09-30
NCT07361302 A Study to Test if Tenecteplase Helps People to Recover From an Acute Stroke When Given… Acute Ischemic Stroke Recruiting 2026-09-29
NCT07366034 A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps… Fibrosing Interstitial Lung Disease Recruiting 2026-09-29
NCT07472517 DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare… Small Cell Lung Cancer (SCLC) Recruiting 2026-09-29
NCT07544654 DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer… Extrapulmonary Neuroendocrine Cancer (epNEC) Recruiting 2026-09-29
NCT07195695 Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely… Non-small Cell Lung Cancer Recruiting 2026-09-17
NCT06806592 A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic… Interstitial Lung Diseases Recruiting 2026-09-16
NCT07107945 A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and… Chronic Kidney Disease Recruiting 2026-09-16
NCT06151574 Beamion LUNG-2: A Study to Test Whether Zongertinib (BI 1810631) Helps People With… Lung Cancer, Non-squamous, Non-small Cell Active, Not Recruiting 2026-10-01
NCT06531824 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With… Kidney Disease, Chronic Active, Not Recruiting 2026-10-01
NCT06238622 A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary… Idiopathic Pulmonary Fibrosis Active, Not Recruiting 2026-09-30
NCT07789015 A Study to Understand How Nerandomilast Works in People With Active Idiopathic… Idiopathic Inflammatory Myopathies Not Yet Recruiting 2026-09-30
NCT07850050 SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With… Obesity Not Yet Recruiting 2026-09-30
NCT07850063 ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and… Obesity Not Yet Recruiting 2026-09-30
Phase 2
NCT06962839 A Study to Test Whether BI 1815368 Helps People With an Eye Condition Called Diabetic… Macular Edema Recruiting 2026-10-01
See all 95 active Boehringer Ingelheim trials with filters →

Disease areas by active trials, top 10 of 27

Lung Cancer (15) · Obesity (9) · Small Cell Lung Cancer (9) · Non-Small Cell Lung Cancer (NSCLC) (6) · Chronic Kidney Disease (4) · Heart Failure (4) · NASH / MASH (4) · Diabetes (3) · Idiopathic Pulmonary Fibrosis (3) · Type 2 Diabetes (3)

Get alerts when Boehringer Ingelheim's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free